Since fibronectin 45–47 which is a key component of the ECM is known to be highly upregulated in cancer 48–53, we further analyzed published proteomic data and found that fibronectin is indeed heavily phosphorylated in clinical cancer tissue samples (Fig.2, Table2). This evidence concerns the gene FN1 and cancer.